Skip to main content

Advertisement

SpringerLink
Log in

Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

Eicosanoid-related enzymes have been implicated in the pathogenesis of various cancers. Little is known about the relevance of lipoxygenase pathway to ovarian cancer growth. In this study, we examined the role of 12-lipoxygenase (12-LOX), the main human 12-HETE generating enzyme, in the regulation of proliferation and survival in epithelial ovarian cancer.

Methods

Immunohistological analysis of 12-LOX expression in high-grade serous ovarian carcinoma and normal ovarian epithelium tissues was performed. The presence of 12-LOX-12-HETE system was confirmed in two epithelial ovarian cancer (EOC) cell lines, OVCAR-3 and SK-OV-3, using RT–PCR, Western blot and LC/MS analysis. The effects of N-benzyl-N-hydroxy-5-phenyl-pentanamide (BMD-122), a specific 12-LOX inhibitor, on cell growth, survival, apoptosis, and cell signaling were determined.

Results

We found that a significantly higher level of 12-LOX expression in high-grade serous ovarian carcinoma compared to normal ovarian epithelium. OVCAR-3 and SK-OV-3 were found to express high level of 12-LOX mRNA and protein. Both EOC increased their 12-HETE production when incubated with arachidonic acid. BMD-122 inhibited the EOC growth in a dose-dependent fashion. Purified 12-HETE significantly reversed such inhibitory effects of BMD-122. In addition, BMD-122 blocked the MAPK signaling pathway by inhibiting the phosphorylation of ERK and induced a ~20–30% increase in the EOC apoptosis. Down-regulation of the 12-LOX expression using 12-LOX siRNA also resulted in markedly reduction in cell growth.

Conclusions

These data suggest that 12-LOX is involved in the regulation of ovarian cancer cell growth and survival and is a potential new therapeutic target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300

    Article  PubMed  Google Scholar 

  2. Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10:181–193

    Article  PubMed  CAS  Google Scholar 

  3. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871–1875

    Article  PubMed  CAS  Google Scholar 

  4. Nie D, Honn KV (2002) Cyclooxygenase, lipoxygenase and tumor angiogenesis. Cell Mol Life Sci 59:799–807

    Article  PubMed  CAS  Google Scholar 

  5. Roman RJ (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131–185

    PubMed  CAS  Google Scholar 

  6. Chen X, Wang S, Wu N, Sood S, Wang P, Jin Z, Beer DG, Giordano TJ, Lin Y, Shih WC, Lubet RA, Yang CS (2004) Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis. Clin Cancer Res 10:6703–6709

    Article  PubMed  CAS  Google Scholar 

  7. de Groot DJ, de Vries EG, Groen HJ, de Jong S (2007) Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Crit Rev Oncol Hematol 61:52–69

    Article  PubMed  Google Scholar 

  8. Brash AR (1999) Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 274:23679–23682

    Article  PubMed  CAS  Google Scholar 

  9. Kuhn H, Thiele BJ (1999) The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett 449:7–11

    Article  PubMed  CAS  Google Scholar 

  10. Bhattacharya S, Mathew G, Jayne DG, Pelengaris S, Khan M (2009) 15-lipoxygenase-1 in colorectal cancer: a review. Tumour Biol 30:185–199

    Article  PubMed  CAS  Google Scholar 

  11. Shureiqi I, Lippman SM (2001) Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 61:6307–6312

    PubMed  CAS  Google Scholar 

  12. Pace-Asciak CR, Granstrom E, Samuelsson B (1983) Arachidonic acid epoxides. Isolation and structure of two hydroxy epoxide intermediates in the formation of 8,11,12- and 10,11,12-trihydroxyeicosatrienoic acids. J Biol Chem 258:6835–6840

    PubMed  CAS  Google Scholar 

  13. Quintana LF, Guzman B, Collado S, Claria J, Poch E (2006) A coding polymorphism in the 12-lipoxygenase gene is associated to essential hypertension and urinary 12(S)-HETE. Kidney Int 69:526–530

    Article  PubMed  CAS  Google Scholar 

  14. Coffey MJ, Jarvis GE, Gibbins JM, Coles B, Barrett NE, Wylie OR, O’Donnell VB (2004) Platelet 12-lipoxygenase activation via glycoprotein VI: involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis. Circ Res 94:1598–1605

    Article  PubMed  CAS  Google Scholar 

  15. Huber J, Furnkranz A, Bochkov VN, Patricia MK, Lee H, Hedrick CC, Berliner JA, Binder BR, Leitinger N (2006) Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase. J Lipid Res 47:1054–1062

    Article  PubMed  CAS  Google Scholar 

  16. Yoshimoto T, Takahashi Y (2002) Arachidonate 12-lipoxygenases. Prostaglandins Other Lipid Media 68–69:245–262

    Article  Google Scholar 

  17. Furstenberger G, Krieg P, Muller-Decker K, Habenicht AJ (2006) What are cyclooxygenases and lipoxygenases doing in the driver’s seat of carcinogenesis? Int J Cancer 119:2247–2254

    Article  PubMed  CAS  Google Scholar 

  18. Gao X, Grignon DJ, Chbihi T, Zacharek A, Chen YQ, Sakr W, Porter AT, Crissman JD, Pontes JE et al (1995) Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology 46:227–237

    Article  PubMed  CAS  Google Scholar 

  19. Timar J, Raso E, Dome B, Li L, Grignon D, Nie D, Honn KV, Hagmann W (2000) Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. Int J Cancer 87:37–43

    Article  PubMed  CAS  Google Scholar 

  20. Leung HW, Yang WH, Lai MY, Lin CJ, Lee HZ (2007) Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol 45:403–411

    Article  PubMed  CAS  Google Scholar 

  21. Wong BC, Wang WP, Cho CH, Fan XM, Lin MC, Kung HF, Lam SK (2001) 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells. Carcinogenesis 22:1349–1354

    Article  PubMed  CAS  Google Scholar 

  22. Chen YQ, Duniec ZM, Liu B, Hagmann W, Gao X, Shimoji K, Marnett LJ, Johnson CR, Honn KV (1994) Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res 54:1574–1579

    PubMed  CAS  Google Scholar 

  23. Connolly JM, Rose DP (1998) Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice. Cancer Lett 132:107–112

    Article  PubMed  CAS  Google Scholar 

  24. Yoshimura R, Inoue K, Kawahito Y, Mitsuhashi M, Tsuchida K, Matsuyama M, Sano H, Nakatani T (2004) Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor. Int J Mol Med 13:41–46

    PubMed  CAS  Google Scholar 

  25. Freedman RS, Wang E, Voiculescu S, Patenia R, Bassett RL Jr, Deavers M, Marincola FM, Yang P, Newman RA (2007) Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer. Clin Cancer Res 13:5736–5744

    Article  PubMed  CAS  Google Scholar 

  26. Guo M, Roman RJ, Fenstermacher JD, Brown SL, Falck JR, Arbab AS, Edwards PA, Scicli AG (2006) 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N′-(4-butyl-2-methylphenol)Formamidine (HET0016), a selective inhibitor of CYP4A. J Pharmacol Exp Ther 317:97–108

    Article  PubMed  CAS  Google Scholar 

  27. Nie D, Tang K, Diglio C, Honn KV (2000) Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase. Blood 95:2304–2311

    PubMed  CAS  Google Scholar 

  28. Matsuyama M, Yoshimura R, Tsuchida K, Takemoto Y, Segawa Y, Shinnka T, Kawahito Y, Sano H, Nakatani T (2004) Lipoxygenase inhibitors prevent urological cancer cell growth. Int J Mol Med 13:665–668

    PubMed  CAS  Google Scholar 

  29. Tong WG, Ding XZ, Witt RC, Adrian TE (2002) Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 1:929–935

    PubMed  CAS  Google Scholar 

  30. Timar J, Raso E, Honn KV, Hagmann W (1999) Human melanoma cell lines12-lipoxygenase expression in. Adv Exp Med Biol 469:617–622

    Article  PubMed  CAS  Google Scholar 

  31. Pidgeon GP, Kandouz M, Meram A, Honn KV (2002) Mechanisms controlling prostate cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in cancer cells. Cancer Res 62:2721–2727

    PubMed  CAS  Google Scholar 

  32. Mebratu Y, Tesfaigzi Y (2009) How ERK1/2 activation controls cell proliferation and cell death: is subcellular localization the answer? Cell Cycle 8:1168–1175

    Article  PubMed  CAS  Google Scholar 

  33. Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21–44

    Article  PubMed  CAS  Google Scholar 

  34. Balmanno K, Cook SJ (2009) Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 16:368–377

    Article  PubMed  CAS  Google Scholar 

  35. Sawe N, Steinberg G, Zhao H (2008) Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res 86:1659–1669

    Article  PubMed  CAS  Google Scholar 

  36. Osaki M, Oshimura M, Ito H (2004) PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9:667–676

    Article  PubMed  CAS  Google Scholar 

  37. Berra E, Milanini J, Richard DE, Le Gall M, Vinals F, Gothie E, Pages G, Pouyssegur J (2000) Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol 60:1171–1178

    Article  PubMed  CAS  Google Scholar 

  38. Downward J (2004) PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 15:177–182

    Article  PubMed  CAS  Google Scholar 

  39. Stiles BL (2009) PI-3-K and AKT: onto the mitochondria. Adv Drug Deliv Rev 61:1276–1282

    Article  PubMed  CAS  Google Scholar 

  40. Jiang WG, Douglas-Jones A, Mansel RE (2003) Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids 69:275–281

    Article  PubMed  CAS  Google Scholar 

  41. Ohd JF, Nielsen CK, Campbell J, Landberg G, Lofberg H, Sjolander A (2003) Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 124:57–70

    Article  PubMed  CAS  Google Scholar 

  42. Gupta S, Srivastava M, Ahmad N, Sakamoto K, Bostwick DG, Mukhtar H (2001) Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer 91:737–743

    Article  PubMed  CAS  Google Scholar 

  43. Boeglin WE, Kim RB, Brash AR (1998) A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression. Proc Natl Acad Sci USA 95:6744–6749

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Women’s Health Services, Gynecological Oncology Research, Henry Ford Health System, One Ford Place, Room 4D99, Detroit, MI, 48202, USA

    Austin M. Guo, Xiuli Liu & Adnan R. Munkarah

  2. Department of Obstetrics and Gynecology, Wayne State University/Karmanos Cancer Institute, Detroit, MI, 48201, USA

    Zaid Al-Wahab

  3. Department of Pathology, Wayne State University, Detroit, MI, 48201, USA

    Krishna Rao Maddippati & Rouba Ali-Fehmi

  4. Eye Care Services, Henry Ford Health System, Detroit, MI, 48201, USA

    A. Guillermo Scicli

  5. Department of Pharmacology, College of Medicine, Wuhan University, Wuhan, People’s Republic of China

    Austin M. Guo

  6. Department of Pharmacology, New York Medical College, 15 Dana Road, BSB 546, Valhalla, NY, 10595, USA

    Austin M. Guo

Authors
  1. Austin M. Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiuli Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zaid Al-Wahab
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Krishna Rao Maddippati
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rouba Ali-Fehmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Guillermo Scicli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Adnan R. Munkarah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Austin M. Guo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guo, A.M., Liu, X., Al-Wahab, Z. et al. Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival. Cancer Chemother Pharmacol 68, 1273–1283 (2011). https://doi.org/10.1007/s00280-011-1595-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-011-1595-y

Keywords

Search

Navigation